Canopy Growth (CGC) Profit After Tax (2019 - 2025)
Canopy Growth's (CGC) quarterly Profit After Tax came in at -$44.9 million in Q4 2025, up 48.53% year-on-year from -$30.2 million in Q4 2024, and down 3670.84% quarter-over-quarter from -$1.2 million in Q3 2025.
Canopy Growth (CGC) Profit After Tax (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Profit After Tax across 7 years of filings, most recently posting -$44.9 million for Q4 2025.
- Profit After Tax for Q4 2025 came in at -$44.9 million, up 48.53% year-over-year; the trailing twelve-month figure through Dec 2025 was -$234.1 million (up 28.84% YoY), and the FY2025 annual result was -$421.0 million, up 13.68% from the prior year.
- Profit After Tax came in at -$44.9 million for Q4 2025 at Canopy Growth, down from -$1.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $317.2 million in Q2 2021 to a low of -$1.6 billion in Q2 2022.
- The 5-year median for Profit After Tax is -$93.5 million (2024), against an average of -$197.7 million.
- Across the five-year window, Profit After Tax soared 442.79% in 2021 and plunged 1614.82% in 2022, its largest moves.
- Canopy Growth's Profit After Tax stood at -$86.4 million in 2021, then slumped by 121.2% to -$191.1 million in 2022, then advanced by 11.51% to -$169.1 million in 2023, then soared by 48.41% to -$87.3 million in 2024, then surged by 48.53% to -$44.9 million in 2025.
- The last three Profit After Tax figures came in at -$44.9 million (Q4 2025), -$1.2 million (Q3 2025), and -$30.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -44.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -44.91 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -29.97 Mn |
| Mar 31, 2025 | -158.07 Mn |
| Dec 31, 2024 | -87.26 Mn |
| Sep 30, 2024 | -94.05 Mn |
| Jun 30, 2024 | -92.96 Mn |
| Mar 31, 2024 | -54.78 Mn |
| Dec 31, 2023 | -169.15 Mn |
| Sep 30, 2023 | -231.25 Mn |
| Jun 30, 2023 | -7.87 Mn |
| Mar 31, 2023 | -327.21 Mn |
| Dec 31, 2022 | -191.15 Mn |
| Sep 30, 2022 | -150.64 Mn |
| Jun 30, 2022 | -1.64 Bn |
| Mar 31, 2022 | -408.19 Mn |
| Dec 31, 2021 | -86.41 Mn |
| Sep 30, 2021 | -8.78 Mn |
| Jun 30, 2021 | 317.24 Mn |
| Mar 31, 2021 | -487.25 Mn |